ASMB Price Targets and Analyst Ratings NASDAQ:ASMB
ASMB Forecast. What You Should Know.
ASMB Historical Ratings and Targets
About Assembly Biosciences
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri... ASMB Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.